The three musketeers of the Congress Party, Sonia Gandhi, Rahul Gandhi and Manmohan Singh, have launched a vicious attack on Prime Minister Narendra Modi and accused him of destroying the Indian economy and causing colossal losses to hapless investors. For once, NAMO’s Bhakts are on the back-foot and maintaining a deafening silence
The Chairman and CEO of a micro-cap company backed by Porinju Veliyath and Ashish Chugh have been held prima facie guilty of insider trading by SEBI and directed to disgorge their alleged ill-gotten gains
Porinju’s chilling warning that the purists are behaving like amateurs by confusing between “good stocks” and “good companies” and by buying so-called high-quality stocks at exorbitant valuations is coming true. The purists are now at a dead end, with nowhere to hide!
Prof Sanjay Bakshi’s favourite stock which supposedly has an “impenetrable moat” around it has fallen off the cliff. Worse, the Company is being likened to Satyam and questions are being raised about the existence of a huge amount of cash on its books. What is the way out for its beleaguered investors?
An ace stock picker who shot to notoriety for trapping short-sellers in the “Mother of all Bear squeezes” and pocketing a fortune of Rs. 350 crore has been arrested for “securities fraud”. Will he be able to bail himself out of the mess?
A punter who devised a devious plan to send the stock price surging or plunging based on bogus tweets has been busted and faces 25 years in jail. Sadly for him, while he caused a market loss of Rs. 8 crore, his gains from the fraud was only Rs. 6,000
After Bill Ackman, Ruane Cunniff, another large shareholder of Valeant Pharma, has rushed to the defense of Valeant Pharma. It complained of experiencing “extraordinary level of pain” at the steep plunge of Valeant’s stock price but gave a clean chit to the beleaguered company and its CEO
Bill Ackman’s Pershing Square Hedge Fund has lost $2 Billion of its investment in Valeant Pharma on the back of allegations that Valeant is an “Enron like fraud”. If a super-savvy investor like Bill Ackman can’t get his investments right, what chance do ordinary investors have?
When a pack of bloodthirsty bears sets its eyes on you, you have to run for your life. However, Eros International is putting up a brave fight and seeking to spook the bears. Who will win this death match?
SKS Microfinace is on a scorching growth trajectory. However, is this growth coming at the cost of lending to junkyard borrowers who have no intention or ability of repaying the loans? This concern has split two ace stock pickers over the prospects for the micro lender
Recent Comments